While there is a tradition that published research be made freely available to the academic community, both for duplication of experiments and for pushing that research in new directions, companies have an interest in protecting the commercial rights to their published work. In seeking to do both, Lexicon Genetics Inc. now finds itself under the gun for alleged transgressions of its pact with academia, a circumstance it did not anticipate when it agreed to a material transfer agreement () as a condition for publishing in